Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2021-05-18

Product name:

OCTASA

Description:

ALSO KNOWN AS MESALAMINE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02465752

Product Monograph/Veterinary Labelling:

Date: 2017-06-30 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

TILLOTTS PHARMA AG
Baslerstrasse 15
Rheinfelden
Aargau
Switzerland  4310

Class: 

Human

Dosage form(s):

Tablet (Delayed-Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

56:36.00   ANTI-INFLAMMATORY AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A07EC02  MESALAZINE

Active ingredient group (AIG) number:See footnote 5

0116808010

List of active ingredient(s)
Active ingredient(s) Strength
MESALAZINE 800 MG

Application information

Related information

Contact us

Version 3.9.1
Date modified: